Treatment of melanoma mice with H1-receptor antagonist blocks HIF-1α expression and suppresses tumor growth and mast cells infiltration, suggesting that mast cell-derived HIF-1α accelerates melanoma growth (74). The gene discussed is HIF1A; the disease is neoplasm.